The Role of Timing in Treatment of Atrial Fibrillation: An AFFIRM Substudy

In contrast to historical trials, EAST-AFNET 4 suggests the superiority of early rhythm control compared to rate control in patients with recent-onset atrial fibrillation (AF). The relative contributions of timing versus improvement in AF therapeutics over time is unclear.

Source: Heart Rhythm - December 28, 2020 Category: Cardiology Authors: Eunice Yang, Olive Tang, Thomas Metkus, Ronald D. Berger, David D. Spragg, Hugh G. Calkins, Joseph E. Marine Source Type: research